You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Breast Cancer Screening: Clinical, Radiologic, and Biochemical

FELDMAN, ELIZABETH D. MD, FACS; OPPONG, BRIDGET A. MD; WILLEY, SHAWNA C. MD, FACS

Clinical Obstetrics & Gynecology:
doi: 10.1097/GRF.0b013e31825ca884
Office Gynecology
Abstract

Breast cancer screening is a highly complex and more recently a controversial topic. Conventional screening includes breast self-examination, clinical breast examination, and screening mammography. Several newer imaging modalities have been introduced into the screening armamentarium including breast magnetic resonance imaging and whole-breast automated ultrasound. Novel imaging techniques like positron emission mammography are currently under clinical investigation in the hopes of improving the sensitivity of breast cancer screening. In addition, the development of biochemical assays, which employ minimally invasive sampling are also promising.

Author Information

Division of Surgical Oncology, Georgetown University Hospital, Washington, District of Columbia

The authors declare that they have nothing to disclose.

Correspondence: Shawna C. Willey, MD, FACS, Betty Lou Ourisman Breast Health Center, Division of Surgical Oncology, Georgetown University Hospital, Washington, DC. E-mail: scw9@gunet.georgetown.edu

© 2012 Lippincott Williams & Wilkins, Inc.